Chad Therapeutics (CHADQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-1993 | 03-1992 | 03-1991 | 03-1990 | 03-1989 | |
| Sales | 5,805 | 3,232 | 1,786 | 952 | 740 |
| Cost of Goods | 2,618 | 1,533 | 1,033 | 541 | 462 |
| Gross Profit | 2,864 | 1,495 | 753 | 411 | 278 |
| Operating Expenses | 1,752 | 1,070 | 890 | 521 | 436 |
| Operating Income | 1,436 | 629 | -137 | -110 | -159 |
| Interest Expense | 8 | 19 | 8 | 0 | 0 |
| Other Income | 8 | 8 | 8 | 6 | 3 |
| Pre-tax Income | 1,436 | 618 | -137 | -104 | -156 |
| Income Tax | 572 | 240 | 0 | 0 | 0 |
| Net Income Continuous | 864 | 378 | -137 | -104 | -156 |
| Net Income Discontinuous | 373 | 195 | 0 | 0 | 0 |
| Net Income | $1,237 | $573 | $-138 | $-104 | $-156 |
| EPS Basic Total Ops | 0.13 | 0.06 | -0.01 | -0.01 | -0.02 |
| EPS Basic Continuous Ops | 0.09 | 0.04 | -0.01 | -0.01 | -0.02 |
| EPS Basic Discontinuous Ops | 0.04 | 0.02 | N/A | N/A | N/A |
| EPS Diluted Total Ops | 0.13 | 0.06 | -0.01 | -0.01 | -0.02 |
| EPS Diluted Continuous Ops | 0.09 | 0.04 | -0.01 | -0.01 | -0.02 |
| EPS Diluted Discontinuous Ops | 0.04 | 0.02 | N/A | N/A | N/A |
| EBITDA(a) | $1,461 | $638 | $-134 | $-104 | $-141 |